← Leaderboards
Robert W Hamill
University Of Vermont &St Agric College
$1,421,486
Attributed
$1,421,486
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $306.5K · FY2005–13$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$1,421,486 · 8
By mechanism
U10$1,252,092 · 1
M01$169,394 · 7
Top collaborators
No co-investigators on record.
Most similar at University Of Vermont &St Agric College
Same institution · by research overlap
- Mercedes R. Rincon$17,614,161
- Michael Radermacher$3,764,699
- Natalia I Gokina$3,187,520
- Paul A. Newhouse$26,261,676
- David Wayne Maughan$4,220,291
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsSafetyParkinson DiseaseAdverse EffectsPharmaceutical PreparationsHuman SubjectNeurodegenerative DisordersMedical CenterNew EnglandNeurologyCollegeMaineAging-Related ProcessMedicineNeuroprotectionAmericanCessation Of LifeDisabilityAccountingClinical AssessmentsAffectHealth Care CostsAlzheimer&AposCost Of Illness
Grant awards (24)
Parkinson Disease Neuroprotection Clinical Trial$98,556
U10 · FY2013 · NS · contact PI
Parkinson Disease Neuroprotection Clinical Trial$80,988
U10 · FY2012 · NS · contact PI
Parkinson Disease Neuroprotection Clinical Trial$90,278
U10 · FY2011 · NS · contact PI
Parkinson Disease Neuroprotection Clinical Trial$188,737
U10 · FY2010 · NS · contact PI
Parkinson Disease Neuroprotection Clinical Trial$85,200
U10 · FY2010 · NS · contact PI
CLINICAL TRIAL: CREATINE IN SUBJECTS WITH TREATED PARKINSON'S DISEASE (PD)$32,522
M01 · FY2010 · RR · contact PI
Parkinson Disease Neuroprotection Clinical Trial$132,313
U10 · FY2009 · NS · contact PI
CLINICAL TRIAL: CREATINE IN SUBJECTS WITH TREATED PARKINSON'S DISEASE (PD)$44,762
M01 · FY2009 · RR · contact PI
Parkinson Disease Neuroprotection Clinical Trial: Clinical Centers$172,300
U10 · FY2008 · NS · contact PI
CLINICAL TRIAL: CREATINE IN SUBJECTS WITH TREATED PARKINSON'S DISEASE$33,721
M01 · FY2008 · RR · contact PI
Parkinson Disease Neuroprotection Clinical Trial: Clinical Centers$68,175
U10 · FY2007 · NS · contact PI
Parkinson Disease Neuroprotection Clinical Trial$30,300
U10 · FY2006 · NS · contact PI
DNA REPOSITORY FOR PATIENTS WITH PARKINSON'S DISEASE$10,640
M01 · FY2006 · RR · contact PI
MULTICENTER STUDY OF COQ10 & GPI 1485 IN EARLY UNTREATED PARKINSON'S DISEASE$3,192
M01 · FY2006 · RR · contact PI
MINOCYCLINE AMP; CREATINE IN EARLY UNTREATED PARKINSON'S DISEASE$2,660
M01 · FY2006 · RR · contact PI
Parkinson Disease Neuroprotection Clinical Trial$30,300
U10 · FY2005 · NS
MULTICENTER STUDY OF COQ10 &GPI 1485 IN EARLY UNTREATED PARKINSON'S DISEASE$16,172
M01 · FY2005 · RR
MINOCYCLINE &CREATINE IN EARLY UNTREATED PARKINSON'S DISEASE$7,855
M01 · FY2005 · RR
DNA REPOSITORY FOR PATIENTS WITH PARKINSON'S DISEASE$925
M01 · FY2005 · RR
Parkinson Disease Neuroprotection Clinical Trial$105,655
U10 · FY2004 · NS
Minocycline &Creatine in early untreated Parkinson's Disease$14,735
M01 · FY2004 · RR
Multicenter Study of CoQ10 &GPI 1485 in Early Untreated Parkinson's Disease$2,210
M01 · FY2004 · RR
Parkinson Disease Neuroprotection Clinical Trial$61,880
U10 · FY2003 · NS
Parkinson Disease Neuroprotection Clinical Trial$107,410
U10 · FY2002 · NS